Edwards Lifesciences heart valve approved in Europe

Edwards Lifesciences Corp. received European approval to market its Edwards Sapien transcatheter aortic heart valve technology with the RetroFlex transfemoral delivery system. The valve, which is implanted through the leg in a minimally invasive procedure, is for patients with severe aortic heart valve stenosis who are not good candidates for conventional open-heart valve replacement surgery.

View Full Article in:

Orange County Business Journal (Irvine, Calif.) · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD